Du Guanhua, Song Junke, Du Lida, Zhang Li, Qiang Guifen, Wang Shoubao, Yang Xiuying, Fang Lianhua
Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Adv Pharmacol. 2020;87:1-41. doi: 10.1016/bs.apha.2019.12.004. Epub 2020 Jan 16.
Danshen, the dried root of Salvia miltiorrhiza Bge, is a common medicinal herb in Traditional Chinese Medicine, which has been used for the treatment of a number of diseases for thousands of years. More than 2000 years ago, the Chinese early pharmacy monograph "Shennong Materia Medica" recorded that Danshen could be used for the treatment of gastrointestinal diseases, cardiovascular diseases, certain gynecological diseases, etc. Since then, Danshen has been widely used clinically in many different prescriptions for many different diseases, especially for the treatment of cardiovascular diseases. Nowadays, many pharmacological studies about the water-soluble components from Danshen have been reported, especially salvianolic acids. It turned out that salvianolic acids showed strong anti-lipid peroxidation and anti-thrombic activities, and among them, SalAA and SalAB were the most potent. This review focused on the achievements in research of salvianolic acids regarding their bioactivities and pharmacological effects. These studies not only shed light on the water-soluble active components of Danshen and their mechanisms at the molecular level, but also provided theoretical information for the development of new medicines from Danshen for the treatment of cardiovascular and cerebrovascular diseases, inflammatory diseases, metabolic diseases, etc.
丹参为唇形科植物丹参干燥根,是一种常见的中药材,数千年来一直用于治疗多种疾病。2000多年前,中国早期药学专著《神农本草经》记载,丹参可用于治疗胃肠道疾病、心血管疾病、某些妇科疾病等。此后,丹参在临床上被广泛应用于多种不同疾病的多种不同方剂中,尤其用于治疗心血管疾病。如今,已有许多关于丹参水溶性成分的药理研究报道,尤其是丹酚酸类。结果表明,丹酚酸类具有较强的抗脂质过氧化和抗血栓形成活性,其中,丹酚酸A和丹酚酸B活性最强。本综述聚焦于丹酚酸类生物活性和药理作用的研究成果。这些研究不仅揭示了丹参的水溶性活性成分及其分子水平的作用机制,还为开发丹参治疗心脑血管疾病、炎症性疾病、代谢性疾病等的新药提供了理论依据。